Tyligand Bioscience Alternatives & Competitors
12 companies similar to Tyligand Bioscience — Innovative small molecule therapeutics for cancer and autoimmune disease treatme...
Companies similar to Tyligand Bioscience
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Tempest Therapeutics
Pioneering the future of cancer treatment with innovative small molecule therapeutics that...
IpiNovyx Bio
We are a drug platform focused on treating autoimmune and inflammatory diseases.
Aquinox Pharmaceuticals
Discovering and developing small molecule therapeutics to treat cancer and inflammatory di...
Rival Readout
Competing with Tyligand Bioscience? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
858 Therapeutics
Discovering innovative small molecule therapeutics for the treatment of cancer
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
VentiRx Pharmaceuticals
Advancing healthcare innovations with targeted therapies for cancer, respiratory, and auto...
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve th...
Tradewind BioScience
Innovative therapeutics for the most aggressive cancers
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
Bioniz, LLC
Pioneering the future of autoimmune and cancer treatment with innovative small peptides an...
AmpliMed Corporation
Innovative oncology therapies paving the way for advanced cancer treatment
About Tyligand Bioscience
Tyligand Bioscience is a biotechnology company founded in 2018 with a focus on developing innovative small molecule therapeutics for cancer and autoimmune disease treatment. Their commitment to discovering and developing small molecule therapeutics has attracted significant investment, with the latest being a Series A...
Small Molecule Therapeutics, Cancer Treatment, Autoimmune Disease Treatment, Drug Discovery, Pharmaceuticals, Medicine, Oncology, Immunology, Patient Health, Tumor Targeting, Health Outcomes
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Tyligand Bioscience: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Tyligand Bioscience on 12 Sep 2024. The 12 companies listed here were last checked between 17 Jun 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.